Tumor-infiltrating CAR-T cells (liver metastases) from EC17 TIW treated cohorts also appeared to have the least expression of double- or triple-positive surface inhibitory receptors, PD1, LAG3, and TIM3 (Figure 8E). This evidence concerns the gene HAVCR2 and neoplasm.